hotspot -WSS

hotspot

author：Wikipedia 2025-09-06 20:53:37 - browse：24

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics’ polarizing ALS treatment, the end of the road for a once-vaunted drug developer, and the sorry state of biotech stocks.

For more on what we cover, here’s the Mojsov story; here’s the latest on BrainStorm; here’s the news on Intercept Pharmaceuticals; here’s more on the biotech market; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Drug repurposing or repositioning? The language matters
Next article： Second xenotransplant done with gene

WSS

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Chamber of Commerce, DOJ clash in court over drug prices

Experts study whether long Covid risk adds up with each reinfection

Intarcia’s device

The struggle to figure out which patients 'deserve' Wegovy

CDC's new outbreak response network to include Northeastern

knowledge

hotspot

Wikipedia

Drug repurposing or repositioning? The language matters

Ukraine and a new approach to mental health in war

Wildfire smoke exposes gaps in outdoor worker protections

Changes to biosimilar regulatory framework must prioritize patients

BioMarin wins approval for gene therapy to treat hemophilia A

FDA weighs limits of animal data in assessing artificial wombs

Malaria cases in Florida and Texas: Here’s what you need to know

Microbiome research is starting to find links to chronic diseases

Medical records are filled with copy

How Vertex's cystic fibrosis drug is changing patients' lives

entertainment

What happened to the House vote on health price transparency?

Thermo Fisher plant for manufacturing gene therapies to expand

FDA weighs limits of animal data in assessing artificial wombs

Second xenotransplant done with gene

Fed up with FDA, ALS advocates consider a take

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

focus

focus

focus

explore